# F573 Ia Clinical Trial

> **NCT04820049** · PHASE1 · COMPLETED · sponsor: **Beijing Continent Pharmaceutical Co, Ltd.** · enrollment: 100 (actual)

## Conditions studied

- Tolerance
- Pharmacokinetic

## Interventions

- **DRUG:** F573
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04820049
- **Lead sponsor:** Beijing Continent Pharmaceutical Co, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-08
- **Primary completion:** 2022-08-02
- **Final completion:** 2022-11-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04820049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04820049, "F573 Ia Clinical Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04820049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*